Yuxuan Hu is a Postgraduate Research Associate in Dr. Dong’s Lab in the Department of Neurology at Yale School of Medicine. He holds a B.S. in Pharmaceutical Administration from China Pharmaceutical University (2017–2021). His research integrates pharmacological knowledge with artificial intelligence–aided drug design and computational biology, as reflected in publications in Cell (2024), Nucleic Acids Research (2022), and Chemical Research in Toxicology (2023), etc. Yuxuan’s current work focuses on drug repurposing for Parkinson’s disease, where he applies deep learning and large-scale, multi-cohort EHR analysis to identify potential therapeutic targets and medications (Hu et al, medRxiv, 2025). Building on his background in target identification and AI-driven drug discovery, he is committed to contributing to The Michael J. Fox Foundation’s mission of accelerating disease-modifying therapies for PD patients. Before joining Yale and Harvard collaborations, he worked as an algorithm intern at XtalPi, focusing on antibody drug discovery. Outside the lab, he enjoys basketball and collaborative teamwork.
Associated Grants
-
From Omics to Action: A Multimodal Pipeline for Druggable Target Discovery and Real-world Validation in PD
2025